Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M309,269Revenue $M70,182Net Margin (%)21.9Altman Z-Score5.4
Enterprise Value $M290,754EPS $5.5Operating Margin %25.9Piotroski F-Score5
P/E(ttm)20.4Beneish M-Score-2.7Pre-tax Margin (%)27.0Higher ROA y-yN
Price/Book4.410-y EBITDA Growth Rate %4.0Quick Ratio1.9Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %5.9Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow19.9y-y EBITDA Growth Rate %-10.6ROA % (ttm)11.7Higher Current Ratio y-yN
Dividend Yield %2.7PEG3.5ROE % (ttm)21.9Less Shares Outstanding y-yY
Payout Ratio %54.0Shares Outstanding M2,759ROIC % (ttm)27.0Gross Margin Increase y-yN

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJYacktman Focused Fund 2016-03-31 Reduce-0.45%$95.75 - $109.14
($103.39)
$ 112.088%Reduce -8.00%2,300,000
JNJT Rowe Price Equity Income Fund 2016-03-31 Reduce-0.33%$95.75 - $109.14
($103.39)
$ 112.088%Reduce -15.23%3,961,300
JNJKen Fisher 2016-03-31 Add0.01%$95.75 - $109.14
($103.39)
$ 112.088%Add 0.35%10,854,263
JNJTweedy Browne 2015-12-31 Reduce-0.45%$93.42 - $105.25
($100.75)
$ 112.0811%Reduce -4.22%3,693,349
JNJFirst Eagle Investment 2015-12-31 Add0.37%$93.42 - $105.25
($100.75)
$ 112.0811%Add 91.19%3,032,177
JNJYacktman Focused Fund 2015-12-31 Reduce-0.17%$93.42 - $105.25
($100.68)
$ 112.0811%Reduce -3.85%2,500,000
JNJDonald Yacktman 2015-12-31 Reduce-0.15%$93.42 - $105.25
($100.75)
$ 112.0811%Reduce -3.23%7,316,129
JNJTom Gayner 2015-12-31 Add0.06%$93.42 - $105.25
($100.75)
$ 112.0811%Add 3.95%605,200
JNJJohn Rogers 2015-12-31 Reduce-0.06%$93.42 - $105.25
($100.75)
$ 112.0811%Reduce -5.94%831,664
JNJCharles Brandes 2015-12-31 Add0.05%$93.42 - $105.25
($100.75)
$ 112.0811%Add 27.50%151,094
JNJJoel Greenblatt 2015-12-31 Buy 0.04%$93.42 - $105.25
($100.75)
$ 112.0811%New holding39,586
JNJKen Fisher 2015-12-31 Add0.03%$93.42 - $105.25
($100.68)
$ 112.0811%Add 1.18%10,815,964
JNJMario Gabelli 2015-12-31 Add0.01%$93.42 - $105.25
($100.75)
$ 112.0811%Add 4.54%332,287
JNJRuane Cunniff 2015-12-31 Reduce-0.01%$93.42 - $105.25
($100.75)
$ 112.0811%Reduce -15.24%64,753
JNJBarrow, Hanley, Mewhinney & Strauss 2015-12-31 Reduce-0.01%$93.42 - $105.25
($100.75)
$ 112.0811%Reduce -0.38%15,342,046
JNJDodge & Cox 2015-12-31 Reduce$93.42 - $105.25
($100.75)
$ 112.0811%Reduce -4.06%35,435
JNJRichard Pzena 2015-12-31 Add$93.42 - $105.25
($100.75)
$ 112.0811%Add 0.03%1,174,524
JNJYacktman Focused Fund 2015-09-30 Add0.17%$90.73 - $101.11
($96.79)
$ 112.0816%Add 4.00%2,600,000
JNJTweedy Browne 2015-09-30 Reduce-0.17%$90.73 - $101.11
($96.79)
$ 112.0816%Reduce -1.60%3,855,936
JNJCharles Brandes 2015-09-30 Buy 0.16%$90.73 - $101.11
($96.79)
$ 112.0816%New holding118,509
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stoffels PaulusChief Scientific Officer 2016-02-17Sell125,000$102.439.42view
Fasolo PeterVP, Global Human Resources 2016-02-03Sell151,385$104.127.65view
Ullmann Michael HVP, General Counsel 2015-11-20Sell17,650$102.479.38view
Caruso Dominic JVP, Finance; CFO 2015-11-02Sell20,569$102.219.66view
Kapusta Ronald AController, CAO 2015-10-23Sell6,239$99.6812.44view
PRINCE CHARLESDirector 2015-08-06Buy2,500$99.2512.93view
PRINCE CHARLESDirector 2015-06-02Buy2,500$99.2212.96view
Stoffels PaulusChief Scientific Officer 2015-04-28Sell187,250$100.7311.27view
Fasolo PeterVP, Global Human Resources 2015-03-05Sell115,307$102.49.45view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.553.25view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    UnitedHealth’s Obamacare Changes to Affect Healthcare Sector Apr 27 2016 
    Johnson & Johnson Beats 1st-Quarter Expectations, Improves Guidance Apr 27 2016 
    How to Know When You Can Retire With Dividend Investing Apr 13 2016 
    Periodic Payments vs. Lump Sum: When's the Right Time to Pull the Plug? Apr 07 2016 
    Dividend and Value Opportunities in the Large-Cap Pharmaceutical Space Apr 05 2016 
    Is Zimmer Biomet Worth the Risk? Apr 01 2016 
    A Cheap Dividend Aristocrat Yielding Over 4% Mar 02 2016 
    Weekly CFO Sells Highlight: Facebook, Johnson & Johnson, PepsiCo Feb 21 2016 
    What To Do When The Stock Market Falls Feb 16 2016 
    Tweedy Browne Trims Stakes in Financial Stocks Feb 12 2016 

    More From Other Websites
    Looking for dividends Apr 29 2016
    Johnson & Johnson’s 1Q16 Valuation Cheat Sheet Apr 29 2016
    Janssen Submits Application to U.S. FDA Seeking Approval of a Mebendazole Chewable Tablet for the... Apr 29 2016
    Correction: Abbott-St Jude Acquisition story Apr 29 2016
    Correction: Abbott-St Jude Acquisition story Apr 29 2016
    Gilead Says European CHMP Adopts Positive Opinion For Its Odefsey For Treating HIV Apr 29 2016
    Zacks Investment Ideas feature highlights: Visa, Johnson & Johnson and Snap-On Incorporated Apr 29 2016
    Drug Stocks Q1 Earnings Preview: AEGR, AERI, MACK, PRTA Apr 29 2016
    Gilead Disappoints, Harvoni Sales Drop 16% Apr 28 2016
    Will Johnson & Johnson (JNJ) Stock Be Helped by Dividend Hike? Apr 28 2016
    AbbVie forges deeper into cancer, as clock ticks for Humira Apr 28 2016
    Johnson & Johnson hikes dividend at shareholders meeting Apr 28 2016
    Johnson & Johnson hikes dividend at shareholders meeting Apr 28 2016
    Johnson & Johnson Boosts Dividend By 6.7% Apr 28 2016
    Biotech Boom May Continue Through Earnings Season Apr 28 2016
    Johnson & Johnson Announces Dividend Increase of 6.7% Apr 28 2016
    Johnson & Johnson raises quarterly dividend to 80 cents vs. 75 cents Apr 28 2016
    10:31 am Johnson & Johnson increases quarterly dividend to $0.80/share from $0.75/share Apr 28 2016
    Johnson & Johnson Announces Dividend Increase of 6.7% Apr 28 2016
    The Zacks Analyst Blog Highlights: Johnson & Johnson, Biogen, Novartis, Baxalta Incorporated and... Apr 28 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)